2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Neutropenia
6
Neoplasms
4
Febrile Neutropenia
4
Fever
3
Sezary Syndrome
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Prolymphocytic
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Infections
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Burkitt Lymphoma
2
Urinary Tract Infections
1
Testicular Neoplasms
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Interventions
relacorilant
5
Nutrition Assessment
4
Hydrochlorothiazide
4
Bevacizumab
3
Amlodipine
3
aliskiren
2
Osilodrostat
2
Lisinopril
2
Labetalol
2
Angiotensin-Converting Enzyme Inhibitors
2
Adrenalectomy
2
ziprasidone
1
sacubitril and valsartan sodium hydrate drug combination
1
pembrolizumab
1
pazopanib
1
lutetium Lu 177 dotatate
1
ganirelix
1
gallium Ga 68 dotatate
1
fimasartan
1
enzalutamide
1
clevidipine
1
cediranib
1
bicalutamide
1
benazepril
1
Zolpidem
1
Warfarin
1
Vitamin D
1
Vecuronium Bromide
1
Vancomycin
1
Urine Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypertension
×
Cefepime
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled